COVID-19 in COPD: A growing concern.
作者信息
Sin Don D
机构信息
UBC Centre for Heart Lung Innovation (HLI), St. Paul's Hospital, Vancouver, BC, Canada.
Division of Respiratory Medicine, University of British Columbia, Vancouver, BC, Canada.
出版信息
EClinicalMedicine. 2020 Sep;26:100546. doi: 10.1016/j.eclinm.2020.100546. Epub 2020 Sep 19.
Abstract
摘要
相似文献
1
COVID-19 in COPD: A growing concern.
EClinicalMedicine. 2020 Sep;26:100546. doi: 10.1016/j.eclinm.2020.100546. Epub 2020 Sep 19.
2
Clinical Outcomes of COVID-19 Infection among Patients with Chronic Obstructive Pulmonary Disease: Findings from the Philippine CORONA Study.
Clin Pract. 2023 Nov 10;13(6):1383-1392. doi: 10.3390/clinpract13060124.
3
Risk Factors for Development and Severity of COVID-19 in COPD Patients.
Front Med (Lausanne). 2021 Aug 9;8:714570. doi: 10.3389/fmed.2021.714570. eCollection 2021.
4
Prevalence, attitude, knowledge, and risk perception towards COVID-19 in COPD patients associated to biomass exposure.
Int J Environ Health Res. 2023 Feb;33(2):170-179. doi: 10.1080/09603123.2021.2013449. Epub 2021 Dec 29.
5
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses.
J Asthma Allergy. 2022 Jun 17;15:811-825. doi: 10.2147/JAA.S360985. eCollection 2022.
6
Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization.
Int J Chron Obstruct Pulmon Dis. 2023 Aug 22;18:1827-1835. doi: 10.2147/COPD.S415621. eCollection 2023.
7
The Complex Association between COPD and COVID-19.
J Clin Med. 2023 May 31;12(11):3791. doi: 10.3390/jcm12113791.
8
Characteristics and Prognosis of COVID-19 in Patients with COPD.
J Clin Med. 2020 Oct 12;9(10):3259. doi: 10.3390/jcm9103259.
9
The Effects of Previous Asthma and COPD on the Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study in South Korea.
J Clin Med. 2021 Oct 9;10(20):4626. doi: 10.3390/jcm10204626.
10
Impact of the COVID-19 pandemic on COPD exacerbations in Japanese patients: a retrospective study.
Sci Rep. 2024 Feb 2;14(1):2792. doi: 10.1038/s41598-024-53389-2.
引用本文的文献
1
Innate immune recognition against SARS-CoV-2.
Inflamm Regen. 2023 Jan 26;43(1):7. doi: 10.1186/s41232-023-00259-5.
2
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in Chronic Obstructive Pulmonary Disease.
Microbiol Spectr. 2022 Aug 31;10(4):e0045922. doi: 10.1128/spectrum.00459-22. Epub 2022 Jul 13.
3
Histopathological and molecular links of COVID-19 with novel clinical manifestations for the management of coronavirus-like complications.
Inflammopharmacology. 2022 Aug;30(4):1219-1257. doi: 10.1007/s10787-022-00999-9. Epub 2022 May 30.
4
Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD.
Medicina (Kaunas). 2022 Feb 8;58(2):254. doi: 10.3390/medicina58020254.
5
Nitric Oxide: The Missing Factor in COVID-19 Severity?
Med Sci (Basel). 2021 Dec 23;10(1):3. doi: 10.3390/medsci10010003.
6
Deciphering Respiratory-Virus-Associated Interferon Signaling in COPD Airway Epithelium.
Medicina (Kaunas). 2022 Jan 13;58(1):121. doi: 10.3390/medicina58010121.
7
Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19.
Tuberc Respir Dis (Seoul). 2022 Jan;85(1):74-79. doi: 10.4046/trd.2021.0121. Epub 2021 Nov 15.
8
Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease.
Pharmaceuticals (Basel). 2021 Sep 26;14(10):979. doi: 10.3390/ph14100979.
9
Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients.
Sci Rep. 2021 Sep 28;11(1):19251. doi: 10.1038/s41598-021-98749-4.
10
Effect of COVID-19-Related Lockdown οn Hospital Admissions for Asthma and COPD Exacerbations: Associations with Air Pollution and Patient Characteristics.
J Pers Med. 2021 Aug 30;11(9):867. doi: 10.3390/jpm11090867.
本文引用的文献
1
SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry.
EClinicalMedicine. 2020 Sep;26:100515. doi: 10.1016/j.eclinm.2020.100515. Epub 2020 Aug 26.
2
COVID-19 and COPD.
Eur Respir J. 2020 Aug 13;56(2). doi: 10.1183/13993003.02108-2020. Print 2020 Aug.
3
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
4
SARS-CoV-2 receptor ACE2 gene expression and RAAS inhibitors.
Lancet Respir Med. 2020 Jun;8(6):e50-e51. doi: 10.1016/S2213-2600(20)30224-1. Epub 2020 May 13.
5
ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19.
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00688-2020. Print 2020 May.
6
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
7
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Eur Respir J. 2019 May 18;53(5). doi: 10.1183/13993003.00164-2019. Print 2019 May.
Zotero 插件